Imerman Angels

http://www.imermanangels.org
Imerman Angels is a federally registered 501(c )(3) not-for-profit organization providing one-on-one cancer support: connecting cancer fighters, survivors and caregivers. Imerman Angels partners a person fighting cancer with someone who has beaten the same type of cancer. One-on-one relationships give a fighter the chance to ask personal questions and get support from someone who is uniquely familiar with their experience. The service is absolutely free and helps anyone touched by any type of cancer, at any cancer stage level, at any age, living anywhere in the world.

Susan G Komen For the Cure

http://www.komenchicago.org
Susan G. Komen fought breast cancer with her heart, body and soul. Throughout her diagnosis, treatments, and endless days in the hospital, she spent her time thinking of ways to make life better for other women battling breast cancer instead of worrying about her own situation. That concern for others continued even as Susan neared the end of her fight. Moved by Susan’s compassion for others and committed to making a difference, Nancy G. Brinker promised her sister that she would do everything in her power to end breast cancer forever.

That promise is now Susan G. Komen for the Cure®, the global leader of the breast cancer movement, having invested nearly $1.5 billion since inception in 1982. As the world’s largest grassroots network of breast cancer survivors and activists, we’re working together to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Susan G. Komen Race for the Cure®, and generous contributions from our partners, sponsors and fellow supporters, we have become the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.

Lungevity Foundation

http://www.lungevity.org
LUNGevity Foundation was founded by seven Chicago-area lung cancer survivors in November 2000 to increase funding for lung cancer research.

Upon being diagnosed with lung cancer, these individuals learned that while tremendous progress had been made in detecting and treating many of the deadliest cancers over the last two decades, little progress had been made to save the lives of individuals diagnosed with lung cancer. This slow progress was due, in great part, to a lack of funding for lung cancer research. While funding for breast, prostate and colorectal cancer research had grown exponentially over the years, there had been no corresponding growth for lung cancer research.